4//SEC Filing
Albers Jeffrey W. 4
Accession 0000950170-25-090585
CIK 0001815442other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 9:00 PM ET
Size
5.3 KB
Accession
0000950170-25-090585
Insider Transaction Report
Form 4
Albers Jeffrey W.
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-25+16,000→ 16,000 totalExercise: $46.47Exp: 2035-06-24→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 25, 2026 and (ii) the date of the next annual meeting of the Issuer's stockholders.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001638474
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 9:00 PM ET
- Size
- 5.3 KB